Neurotropism is a major feature associated with rabies virus infection, with viral replication restricted almost exclusively to neuronal tissue (7) . Several investigators have shown that rabies virus replicates in muscle cells prior to its invasion of the peripheral and central nervous system (1, 3, 7) . After muscle cell infection, virus may invade peripheral nerves, with virus entry into unsheathed nerve tissue presumably facilitated by the nicotinic acetylcholine receptor of the neuromuscular junction (6) . In contrast to observations in which muscle cell infection occurs during early rabies virus replication, other studies have demonstrated that primary infection of muscle cells may not be necessary (2, 4) . Exposed sensory and, alternatively, motor nerve endings might serve as the primary site of virus attachment and entry. In order to obtain more precise information about the sites where rabies virus is retained following infection, we have used a sensitive polymerase chain reaction (PCR) amplification assay to investigate the early events of rabies virus infection in a mouse model.
Six-week-old female ICR mice (Harlan Sprague-Dawley) were infected intramuscularly in each masseter muscle with 50 ,ul of a mouse brain suspension containing 3.75 x 104 PFU of the mouse-adapted rabies strain CVS-24 (Wistar stock virus). At different times after virus inoculation, two mice at each time point were killed by CO2 intoxication, and the masseter muscles, trigeminal ganglia, and brain tissue were collected. The brain was dissected into brain stem, cerebellum, midbrain, and forebrain. Immediately after harvesting, all tissue samples were homogenized in 4 M guanidine isothiocyanate containing 50 mM Tris-HCl (pH 7.2), 10 mM EDTA, and 1% 2-mercaptoethanol. The RNA was then extracted by the standard guanidine isothiocyanate-CsCl gradient centrifugation method as described before (8) .
The RNA (1 to 1. Oligomers, both upstream and downstream of a conserved region of the N protein gene of the ERA strain of rabies, were synthesized in order to amplify a 647-bp segment of the N gene (nucleotides 248 to 896). The nucleotide sequences of the oligonucleotide primers used for PCR are as follows: antisense primer, 5'-AGAATTCCCACTCAAGCCTAGTG AACGG-3'; sense primer, 5'-GGAATTCTCCGGAAGACT GGACCAGCTATGG-3'. These primers were also used to selectively prime either the positive-strand viral mRNA or the negative-strand viral genomic RNA in the reverse transcriptase reaction. An aliquot of the PCR products was analyzed on a composite gel containing 3% NuSieve agarose and 1% SeaKem agarose (FMC Bioproducts). The gels were blotted onto Gene Screen nylon membranes (Du Pont), hybridized to 32P-labeled specific oligomer, and exposed to Kodak X-Omat-R film at -80°C. The nucleotide sequence of the hybridization probe is 5'-GGCCGGAACCTATGACAT GTTTTTCTCCCG-3'.
To determine the amount of rabies virus-specific RNA detectable after PCR amplification, total RNA was isolated from 0.5 ml of mouse brain homogenate containing 1.5 x 107 PFU of CVS-24 strain virus. Serial dilutions of the RNA were prepared, and an aliquot of each dilution was subjected to PCR. The smallest amount of virus-specific RNA that was detected after PCR amplification (Fig. 1 ) corresponded to 9 PFU of rabies virus present in the brain tissue homogenate.
At 1 h postinfection (p.i.), virus-specific RNA was detected only at the site of inoculation (masseter muscle, Fig.  2A) . The time during which virus-specific RNA could be detected at the inoculation site was extremely short. The observation that no virus-specific RNA was found in the masseter muscle between 6 and 30 h after infection indicated Quantitative analyses of rabies virus-specific RNA isolated from mouse brain and amplified by PCR. Total RNA was extracted from 0.5 ml of suckling mouse brain suspension containing 1.5 x 107 PFU of CVS-24 virus, and 1/200 of the total RNA was serially diluted (twofold). Each dilution was subjected to reverse transcription, and one-fourth of the reverse transcription product was amplified by PCR. One-fourth of the amplified rabies virus cDNA was then resolved on an agarose gel, transferred to nitrocellulose, and analyzed as described in the text.
that the majority of the inoculated virus was rapidly cleared and no significant virus replication had taken place at the inoculation site within the first 30 h p.i. In contrast, the PCR analysis demonstrated that as early as 18 h after intramuscular infection, virus-specific RNA was present in the trigeminal ganglia (Fig. 2B ), and at 24 h p.i. virus-specific RNA could be identified in the brain stem (Fig. 1C) . At 30 and 36 h p.i., the intensity of the amplified rabies virus gene segment increased in the brain stem and trigeminal ganglia, and at 42 h p.i., virus-specific RNA could be detected in the cerebellum (Fig. 2D) . Virus-specific RNA was present in the midbrain and forebrain at 48 h p.i. (Fig. 1E and F) , and at 72 and 96 h p.i. intense replication and spread of virus into all regions of the brain was observed (Fig. 2B through F) .
Although virus-specific RNA disappeared from the masseter muscle at 6 h p.i., it could be detected again at 36 h p.i. Selective amplification of rabies virus-specific positiveand negative-strand RNA isolated from the masseter muscle at different times after infection. Total RNA (1 ,ug) isolated from masseter muscle at 1, 12, 18, and 96 h p.i. was reverse-transcribed with either an antisense (A) or sense (S) primer. The reverse transcription products were then subjected to PCR amplification and analyzed as described in the text.
( Fig. 2A) . To determine whether virus replication occurred in muscle cells, virus-specific plus-or minus-strand RNA isolated from the masseter muscle at 1, 12, 18, and 96 h p.i. was selectively amplified by using antisense and sense primers (Fig. 3) . While the majority of virus-specific RNA isolated at 1 h p.i. represented negative-strand RNA, most of the RNA isolated at 96 h p.i. was positive-strand RNA, suggesting that virus replication may take place in muscle cells in later stages of the infection.
When mice were inoculated with a cocktail of anti-rabies virus monoclonal antibodies 24 h prior to infection, as described previously (9), no virus-specific RNA was detected at 24, 48, and 72 h p.i. in the masseter muscle, trigeminal ganglia, or brain stem, indicating that the infection of and replication in these tissues were blocked by the antibodies (Fig. 4) . Our PCR amplification data clearly indicate that under the experimental conditions applied in this study, rabies virus enters sensory and motor nerve endings shortly after intramuscular inoculation. The virus is (9) . After 24 h, the treated (+) and untreated (-) animals were injected with CVS-24 virus as described in the legend to Fig. 2 . At 24, 48, and 72 h p.i., RNA was isolated from (A) masseter muscles, (B) trigeminal ganglia, and (C) brain stem, subjected to PCR, and analyzed as described in the text.
VOL. 65, 1991 on September 30, 2017 by guest http://jvi.asm.org/ Downloaded from then transported, probably by retrograde axonal flow, to neuronal cells in the trigeminal ganglia and brain stem, where primary replication is initiated. In this mouse model, primary replication of virus in muscle cells prior to invasion of the nervous system apparently did not occur. The detection of virus-specific RNA in the trigeminal ganglia at 18 h p.i. indicates that virus must have entered the nerve endings shortly after inoculation. Virus replication in the trigeminal ganglia can occur 16 to 18 h after intramasseter inoculation, assuming that (i) the time needed for absorption and penetration is approximately 1 to 2 h (10); (ii) the average speed for axonal transport is 1 mm/h (5); and (iii) the time of a replication cycle is 12 h (11) . These estimates are in good agreement with the experimental data. Coulon et al. (2) also found that rabies virus penetrates both sensory and motor routes directly with equal efficiency, without prior multiplication in muscle cells.
Previously, we have shown that mice treated with a cocktail consisting of rabies virus-specific neutralizing monoclonal antibody before a peripheral rabies virus challenge infection were completely protected (9) . In the current work, we have demonstrated that invasion of rabies virus into the nervous system is blocked in mice treated with anti-rabies virus monoclonal antibodies prior to infection. When the mice were treated 2 h after virus inoculation, 43% of the animals succumbed to rabies virus infection (9) , suggesting that in some animals the virus had already entered the nervous system at the time of antibody administration and therefore was no longer accessible to the antibodies.
Although there was no evidence for virus replication in muscle cells within the first 30 h p.i., virus-specific RNA could be detected again in the masseter muscle at 36 h p.i. The observation that most of the rabies virus-specific RNA isolated and amplified from the masseter muscle at 96 h p.i. was in the positive sense suggests that virus replication had taken place in the masseter muscle. It is difficult to determine whether virus replication in muscle tissue is the result of primary infection of muscle cells or the result of a second cycle of virus replication initiated by virions transported centrifugally from the infected neurons of the trigeminal ganglia or brain stem back to the masseter muscle. The significance of virus replication in muscle in our virus-animal system is not clear. A direct comparison of our data with those of other investigators is difficult because of differences in animal models, such as hamsters (7) and carnivores (1, 3) , as well as differences in doses and routes of inoculation of either fixed or street rabies virus strains. However, since there is an interplay between virus strain and host, primary replication in muscle may be important in certain virusanimal systems (1, 3, 7) . To determine the relevance of primary virus replication in muscles, we will perform pathogenesis studies in relevant target animals with street rabies virus instead of fixed rabies virus strains.
